Atlas Trials

Recurrent Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma

RecordFirmDate
Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma (NCT05821088)David Bond, MD2023-06-29

Track Recurrent Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.